This paper is in the following e-collection/theme issue:

Cross-Sectional Studies in Public Health (453) Substance Abuse (547) Prevention and Health Promotion (1428) Adverse Drug Events Detection, Pharmacovigilance and Surveillance (223) Digital Pain Assessment and Management (246) Chronic Conditions (464) Public (e)Health, Digital Epidemiology and Public Health Informatics (1055)

Published on in Vol 10 (2024)

This is a member publication of Imperial College London (Jisc)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/57595, first published .
Illicit Cannabis Use to Self-Treat Chronic Health Conditions in the United Kingdom: Cross-Sectional Study

Illicit Cannabis Use to Self-Treat Chronic Health Conditions in the United Kingdom: Cross-Sectional Study

Illicit Cannabis Use to Self-Treat Chronic Health Conditions in the United Kingdom: Cross-Sectional Study

Authors of this article:

Simon Erridge1, 2 Author Orcid Image ;   Lucy Troup3 Author Orcid Image ;   Mikael Hans Sodergren1, 2 Author Orcid Image
Article Authors Cited by (9) Tweetations (18) Metrics

Journals

  1. Savio M, Kearney H, Downer E. Neurologists’ perspectives of cannabis-based medicines: results from an all-Ireland survey. Irish Journal of Medical Science (1971 -) 2025;194(2):687 View
  2. Erridge S, Hall M, Sodergren M. Prevalence and Patterns of Cannabis Product Adulteration: An Analysis of WEDINOS Data. Journal of Psychoactive Drugs 2025:1 View
  3. Eldering L, Kiew I, Lee W, Seah D, Chye R. Perceptions and interests of cannabis use among patients with cancer: A cross-sectional survey. Palliative Medicine 2025;39(8):910 View
  4. Reeves C, Franks L, Kelley A, Incze M, Gordon A, Yu Z, Flake E, Cochran G. Understanding motives for illicit medicinal cannabis use: an exploratory analysis in a medical cannabis program. Journal of Cannabis Research 2025;7(1) View
  5. Tudorancea I, Stanciu G, Solcan C, Ciorpac M, Szilagyi A, Ababei D, Gogu R, Tamba B. Exploring the impact of chronic intermittent EU-GMP certified Cannabis sativa L. therapy and its relevance in a rat model of aging. Journal of Cannabis Research 2025;7(1) View
  6. Erridge S, Chandan J, Gokhale K, Billinghurst C, Sodergren M. Cannabis Use and Analgesic Prescribing in UK Primary Care: A Retrospective Cohort Study of Patients with Osteoarthritis. Medicines 2025;12(4):27 View
  7. Strada L, Korteling S, Vergeer M, Oomen P. Medicinal use of non-prescribed cannabis: a cross-sectional survey on patterns of use, motives for use, and treatment access in the Netherlands. Journal of Cannabis Research 2025;8(1) View
  8. McLaren K, Erridge S, Sodergren M. A Scoping Systematic Review of Cannabis Use in Endometriosis. Australian and New Zealand Journal of Obstetrics and Gynaecology 2025 View
  9. Erridge S, Clarke E, McLachlan K, Coomber R, Beri S, Khan S, Weatherall M, Platt M, Rucker J, Mediano P, Sodergren M. Clinical Outcomes and Patient Profiles in the UK Medical Cannabis Registry: A k‐Means Clustering Analysis. The Journal of Clinical Pharmacology 2026;66(1) View